Chugai Pharmaceutical researchers awarded Lasker-DeBakey Clinical Medical Research Award
Story essentials
Dr. Kunihiro Hattori, Dr. Takehisa Kitazawa, Dr. Tomoyuki Igawa (Chugai Pharmaceutical)
New York, USA
September 9, 2026
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR editorial team brings together public reporting and links to the original coverage. We update the page as new information emerges.
Read our editorial policy- Earlier version 19/9/2026, 3:40:40 PM
Three Chugai researchers recognized for the invention of Hemlibra (emicizumab). Hemlibra is a bispecific antibody for hemophilia A treatment. Marks the second time Japanese researchers have received this award in the clinical category.
Read next
Prioritized by shared people, places, and events.
US to reduce tariffs on Canadian goods
The US is expected to withdraw 50% of tariffs on certain Canadian goods. The move aims to assist Republicans in trade-dependent states ahead of midterm elections. Senator Susan Collins has advocated for this relief.